Novartis
NVS
NVS
761 hedge funds and large institutions have $18.7B invested in Novartis in 2013 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 282 increasing their positions, 294 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
761
Holders Change
-2
Holders Change %
-0.26%
% of All Funds
24.68%
Holding in Top 10
55
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+1.85%
% of All Funds
1.78%
New
53
Increased
282
Reduced
294
Closed
47
Calls
$102M
Puts
$79.7M
Net Calls
+$22.5M
Net Calls Change
-$15.5M
Top Buyers
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$88.1M |
| 2 |
EAM
Edge Asset Management
Seattle,
Washington
|
+$67M |
| 3 |
JPMorgan Chase & Co
New York
|
+$46.8M |
| 4 |
Renaissance Technologies
New York
|
+$32.5M |
| 5 |
Bank of New York Mellon
New York
|
+$24.5M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$148M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$52.6M |
| 3 |
Neuberger Berman Group
New York
|
-$49.5M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$48.1M |
| 5 |
Two Sigma Investments
New York
|
-$30.8M |
